Aligos Therapeutics

Filed a patent for "methods and compositions for targeting pd-l1" on Thu, July 13, 2023

Filed a patent for "hepatitis b combination therapies" on Thu, January 26, 2023

Filed a patent for "pnpla3-targeting short interfering rna (sirna) molecules and uses thereof" on Tue, February 28, 2023

Filed a patent for "short interfering nucleic acid (sina) molecules for targeting angptl 3 and angptl 8 and methods of using the same" on Thu, April 27, 2023

Filed a patent for "methods and compositions for targeting pd-l1" on Thu, November 14, 2024

Filed a patent for "methods and compostitions for targeting pd-l1" on Thu, August 22, 2024

Filed a patent for "methods and compostitions for targeting pd-l1" on Fri, January 20, 2023

Filed a patent for "anti-viral compounds" on Wed, July 6, 2022

Filed a patent for "modified short interfering nucleic acid (sina) molecules and uses thereof" on Thu, May 25, 2023

Filed a patent for "anti-viral compounds" on Thu, May 4, 2023

Filed a patent for "bicyclic compounds" on Fri, September 30, 2022

Filed a patent for "anti-viral compounds" on Thu, October 13, 2022

Filed a patent for "anti-viral compounds" on Mon, October 17, 2022

Filed a patent for "modified short interfering nucleic acid (sina) molecules and uses thereof" on Wed, November 2, 2022

Filed a patent for "anti-viral compounds" on Wed, November 2, 2022

Filed a patent for "methods and compositions for targeting pd-l1" on Thu, June 22, 2023

Filed a patent for "bicyclic compounds" on Thu, February 9, 2023

Filed a patent for "bicyclic compounds" on Thu, February 9, 2023

Filed a patent for "bicyclic compounds" on Thu, November 23, 2023

Filed a patent for "anti-viral compounds" on Thu, January 18, 2024

Filed a patent for "anti-viral compounds" on Mon, July 10, 2023

Filed a patent for "bicyclic compounds" on Thu, November 30, 2023

Filed a patent for "pyrrole compounds" on Thu, December 7, 2023

Filed a patent for "bicyclic compounds" on Thu, May 9, 2024

Filed a patent for "anti-viral compounds" on Thu, April 4, 2024